VKTX has risen on sympathy to the perceived value increase of another NASH play.
VKTX has a Ph2 NASH study that will read out in H-2/18.
The bull case is that VKTX Ph1 data could be interpreted as stronger than the Ph1 data of MDGL
The bear case is that VKTX has undergone > than 100% dilution in the last year at lower pps plus an outstanding ATM agreement with Lincol Park Capital.
Pay attention to relative MC of VKTX,MDGL & ICPT. I believe ICPT is a better stock to stalk short.